Skip to main content

Neuroendocrine Tumors

A Real-World Observational Study of Somatostatin Analog Use and Costs in Canada

Efficacy of Somatostatin Analog Monotherapy for Grade 3 GEP-NETs

Carcinoid Syndrome Improvements in Patients Receiving Telotristat Ethyl: Findings from TELEPRO-II

Safety in Patients with NETs Receiving Telotristat Ethyl with Peptide Receptor Radionuclide Therapy

Efficacy of Telotristat Ethyl in Patients with Progressive NET Disease: Real-World Clinical Practice Experience

Health-Related Quality-of-Life Results of Surufatinib in Advanced Extrapancreatic NETs (SANET-ep Trial)

Efficacy and Safety of Surufatinib in NETs

Subgroup Analysis by Ki67 and Primary Tumor Origins of the Phase 3 SANET-ep Study of Surufatinib

Retreatment PRRT with 177Lu-DOTATATE in Patients with NETs: Multicenter, Real-World Experience

Impact of Treatment Order and Combination on Mortality Outcomes in 177Lu-DOTATATE–Treated Patients with Metastatic GEP-NETs

1
2
3
4

Page 3 of 4
Results 21 - 30 of 31